List of insiders holdings for Audentes Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC ISALY SAMUEL D 10% Owner | 2019-02-12 17:44:56 | 1,893,500 0 | 1,893,500 | Form 13G |
| ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner | 2019-02-12 17:44:56 | 1,893,500 0 | 1,893,500 | Form 13G |
| 5AM Partners III LLC 5AM Co-Investors III L.P. 5AM VENTURES III L.P. DIEKMAN JOHN D Schwab Andrew J. ROCKLAGE SCOTT M former 10% owner | 2019-02-13 16:21:35 | 1,514,544 0 | 1,514,544 | Form 13G |
| Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 2018-02-13 15:08:23 | 1,204,615 0 | 1,204,615 | Form 13G |
| Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT CO Deerfield Special Situations Fund L.P. Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. Possible Member of 10% Group 10% Owner | 2018-02-14 08:46:30 | 1,190,516 0 | 1,190,516 | Form 13G |
| GRAY JOHN T. SVP, Chief Scientific Officer | 2018-10-02 19:03:09 | 71,669 0 | 71,669 | Form 4 |
| Nagler David SVP, HR & Corp. Affairs | 2018-06-22 19:11:16 | 32,347 0 | 32,347 | Form 4 |
| SILVERSTEIN JONATHAN Director 10% Owner | 2016-08-25 21:53:59 | 18,000 0 | 18,000 | Form 4 |
| Woiwode Thomas Director | 2016-08-25 21:55:29 | 18,000 0 | 18,000 | Form 4 |
| PRASAD SUYASH Senior VP & Chief Med Officer | 2019-06-07 16:42:25 | 17,479 0 | 17,479 | Form 4 |
| Versant Ventures IV LLC 10% Owner | 2016-07-25 17:08:44 | 0 11,308 | 11,308 | Form 4 |
| PARMAR KUSH Director | 2018-06-08 17:23:02 | 10,000 0 | 10,000 | Form 4 |
| SQUINTO STEPHEN P Director | 2017-10-10 18:08:25 | 9,000 0 | 9,000 | Form 4 |
| NEWMAN MARY SVP, Regulatory Affairs | 2018-11-16 18:41:18 | 660 0 | 660 | Form 4 |
| Conner Edward R. SVP, Chief Medical Officer | 2020-01-15 13:26:41 | 0 0 | 0 | Form 4 |
| Goldberg Mark Alan Director | 2020-01-15 13:27:58 | 0 0 | 0 | Form 4 |
| Holles Natalie C. President and COO | 2020-01-15 13:29:15 | 0 0 | 0 | Form 4 |
| Jarrett Jennifer Director | 2020-01-15 13:30:09 | 0 0 | 0 | Form 4 |
| LANGE LOUIS G Director | 2020-01-15 13:31:06 | 0 0 | 0 | Form 4 |
| Meltz Mark A SVP, General Counsel | 2020-01-15 13:32:23 | 0 0 | 0 | Form 4 |
| Morrison Scott W Director | 2020-01-15 13:33:13 | 0 0 | 0 | Form 4 |
| Mosbrooker Eric SVP, Chief Commercial Officer | 2020-01-15 13:34:13 | 0 0 | 0 | Form 4 |
| Patterson Matthew R Chief Executive Officer | 2020-01-15 13:35:20 | 0 0 | 0 | Form 4 |
| Schuetz Thomas J. Director | 2020-01-15 13:36:26 | 0 0 | 0 | Form 4 |
| Smith Julie Director | 2020-01-15 13:37:34 | 0 0 | 0 | Form 4 |
| Soloway Thomas P Executive Vice President, CFO | 2020-01-15 13:38:39 | 0 0 | 0 | Form 4 |